Singapore research team identifies new drug target in deadly form of leukemia

A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia , making it possible to develop drugs that may extend the survival of these patients.

http://www.innovations-report.com/html/reports/life_sciences/singapore_research_team_identifies_drug_target_214992.html